ARP-4: A Protein Regulating DNA Replication in Eukaryotic Cells

Target Name: Adaptor-related protein complex 4

NCBI ID: P7028

Adaptor-related protein complex 4

Other Name(s): None

ARP-4: A Protein Regulating DNA Replication in Eukaryotic Cells

Adaptor-related protein complex 4 (ARP-4) is a protein that plays a critical role in the regulation of DNA replication in eukaryotic cells. It is composed of several subunits that are involved in the recruitment of different DNA replication factors to the site of DNA replication. ARP-4 is a key regulator of DNA replication, and it is dysregulated in many diseases, including cancer. As a result, targeting ARP-4 has been identified as a potential drug target or biomarker for a variety of diseases.

The ARP-4 protein complex is composed of several subunits that include the protein ARP-4, ARP-1, and ARP-2. These subunits are involved in the recruitment of different DNA replication factors to the site of DNA replication. ARP-4 is the largest subunit of the ARP-4 complex and is responsible for the recruitment of ARP-1 and ARP-2. ARP-1 and ARP-2 are smaller subunits that are involved in the recruitment of different DNA replication factors, including the S.P.I.N.A. protein and theprotin protein.

ARP-4 plays a critical role in the regulation of DNA replication by recruiting different DNA replication factors to the site of DNA replication. It does this by interacting with the DNA replication factor S.P.I.N.A. The interaction between ARP-4 and S.P.I.N.A. is critical for the recruitment of S.P.I.N.A. to the site of DNA replication.

ARP-4 is also involved in the regulation of DNA replication by recruiting theprotin protein to the site of DNA replication. The interaction between ARP-4 and theprotin protein is critical for the recruitment of theprotin protein to the site of DNA replication.

In addition to its role in the regulation of DNA replication, ARP-4 is also involved in the regulation of cell signaling pathways. It does this by interacting with several different signaling pathways, including the TOR signaling pathway and the PI3K/Akt signaling pathway. These interactions between ARP-4 and signaling pathways are critical for the regulation of cell signaling pathways and for the maintenance of cellular homeostasis.

Targeting ARP-4 as a drug target or biomarker has the potential to lead to a variety of therapeutic benefits. For example, by inhibiting the interaction between ARP-4 and S.P.I.N.A. or theprotin protein, it may be possible to inhibit the regulation of DNA replication and cancer growth. Similarly, by activating the interaction between ARP-4 and the TOR signaling pathway or the PI3K/Akt signaling pathway, it may be possible to promote the regulation of DNA replication and cell growth.

In conclusion, Adaptor-related protein complex 4 (ARP-4) is a protein that plays a critical role in the regulation of DNA replication in eukaryotic cells. It is composed of several subunits that are involved in the recruitment of different DNA replication factors to the site of DNA replication. ARP-4 is dysregulated in many diseases, including cancer, and targeting it as a drug target or biomarker has the potential to lead to a variety of therapeutic benefits. Further research is needed to fully understand the role of ARP-4 in the regulation of DNA replication and to develop effective therapies based on its targeting.

Protein Name: Adaptor-related Protein Complex 4

The "Adaptor-related protein complex 4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Adaptor-related protein complex 4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets